Skip to main content

Table 1 Baseline characteristics of all patients in the study and control groups

From: Impact of the COVID-19 pandemic on subcutaneous venous port-related complications in patients with cancer: a retrospective case–control study

  Study group Control group p-value
n = 257 n = 168
Sex n (%)    0.901
 Female 153 (59.5) 99 (58.9)  
 Male 104 (40.5) 69(41.1)  
Age (years) median (min–max) 65 (19–89) 65 (30–89) 0.864
Cancer, n (%)    < 0.001
 Breast 60 (23.3) 67 (39.9)  
 Colorectal 39 (15.2) 35 (20.8)  
 Upper GI 40 (15.6) 20 (11.9)  
 Urogenital 13 (5.1) 27 (16.1)  
 Haematologic cancer 56 (21.8) 0 (0)  
Others 26 (10.1) 19 (11.3)  
Gyn 23 (8.9) 0 (0)  
Treatment strategy, n (%)    0.182
 Adjuvant 147 (57.2) 107 (63.7)  
 Palliative 110 (42.8) 61 (36.3)  
  1. GI gastrointestinal, Gyn gynaecological